The New York Times, 2004.
60. G. Taubes, “Diet Advice That Ignores Hunge”, The New York Times, 2015.
61. A. Fildes, J. Charlton, C. Rudisill, P. Littlejohns, A.T. Prevost, M. C. Gulliford, “Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records”, American Journal of Public Health, 2015.
62. C. D Gardner, A. Kiazand, S. Alhassan, S. Kim, R. S. Stafford, R. R. Balise, H. C. Kraemer, A. C. King, “Comparison of the Atkins, Zone, Ornish and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial”, JAMA, 2007.
63. J. Sacner-Bernstein, D. Kanter, S. Kau, “Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis”, PLOS One, 2015.
64. N. Mansoor, K. J. Vinknes, M. B. Veierød, K. Retterstøl, “Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials”, British Journal of Nutrition, 2016: 466–479.
65. Y. Hashimoto, T. Fukuda, C. Oyabu, M. Tanaka, M. Asano, M. Yamazaki, M. Fukui, “Impact of low-carbohydrate diet on body composition: meta-analysis of randomized controlled studies”, Obesity Reviews, no. 6, 2016: 499–509.
66. Randomised Controlled Trials (RCTS), Public Health Collaboration. Режим доступа: https://phcuk.org/RCTs/.
67. Z. Harcombe, J. S. Baker, S. M. Cooper, B. Davies, N. Sculthorpe, J. J. DiNicolantonio, F. Grace, “Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis”, BMJ, 2015.
68. P. W. Siri-Tarino, Q. Sun, F. B. Hu, R. M. Krauss, “Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease”, The American Journal of Clinical Nutrition, no. 3, 2010: 535–546.
69. L. A. Bazzano, T. Hu, K. Reynolds, L. Yao, C. Bunol, Y. Liu, Chung-Shiuan Chen, M. J. Klag, P. K. Whelton, J. He, “Effects of Low-Carbohydrate and Low-Fat Diets. A Randomized Trial”, Annals of Internal Medicine, 2014.
70. А. Г. Плугов, «Мировой рынок семян подсолнечника, подсолнечного масла и подсолнечного шрота в 2001–2014 гг.», Экспертно-аналитический центр агробизнеса, 2015. Режим доступа: https://ab-centre.ru/articles/mirovoy-rynok-semyan-podsolnechnika-podsolnechnogo-masla-i-podsolnechnogo-shrota-v-2001-2014-gg.
71. T. L. Blasbalg, J. R. Hibbeln, C. E. Ramsden, S. F. Majchrzak, R. R. Rawlings, “Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century”, The American Journal of Clinical Nutrition, 2011: 950–962.
72. A. R. Alvheim, M. K. Malde, D. Osei-Hyiaman, Y. H. Lin, R. J. Pawlosky, L. Madsen, K. Kristiansen, L. Frøyland, J. R. Hibbeln, “Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity”, Obesity, 2012.
73. F. Massiera, P. Saint-Marc, J. Seydoux, T. Murata, T. Kobayashi, S. Narumiya, P. Guesnet, Ez-Zoubir Amri, R. Negrel, G. Ailhaud, “Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?”, Journal of lipid research, no. 2, 2003: 271–279.
74. G. C. Burdge, “Metabolism of alpha-linolenic acid in humans”, PLEFA, no. 3, 2003: 161–168.
75. Fried food risks: Toxic aldehydes detected in reheated oil, Plataforma SINC, 2012. Режим доступа: https://www.sciencedaily.com/releases/2012/02/120222093508.htm.
76. A. Malhotra, “The toxic truth about vegetable oil: Cooking with ‘healthy’ fats increases the risk of heart disease, type 2 diabetes and cancer”, Mail Online, 2016. Режим доступа: https://www.dailymail.co.uk/health/article-3574810/The-toxic-truth-vegetable-oil-Cooking-healthy-fats-increases-risk-heart-disease-type-2-diabetes-cancer.html.
77. R. Rettner, “Say Goodbye to Trans Fat: FDA Officially Bans Ingredient”, Live Science, 2015. Режим доступа: https://www.livescience.com/51227-trans-fat-ban-official.html.
78. Mayo Clinic Staff, “Trans fat is double trouble for your heart health”, Mayo Clinic, 2020. Режим доступа: https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/trans-fat/art-20046114?pg=2.
79. О. Игнатова, «Прощай, маргарин», Российская газета, вып. 5, 2018.
80. Fatty Acid Comparisons of Grain and Forage-Fed Pork, Practical farmers of Iowa, 2019. Режим доступа: https://practicalfarmers.org/research/fatty-acid-comparisons-of-grain-and-forage-fed-pork/.
81. M. Yu, Q. Gao, Y. Wang, W. Zhang, L. Li, Y. Wang, Y. Dai, “Unbalanced omega-6/omega-3 ratio in red meat products in China”, The Journal of Biomedical Research, no. 5, 2013: 366–371.
82. G. Durankiev, “11 Countries that Consume the Most Mayonnaise”, Insider Monkey, 2015. Режим доступа: https://www.insidermonkey.com/blog/11-countries-that-consume-the-most-mayonnaise-349914/.
83. C. H. S. Ruxton, S. C. Reed, M. J. A. Simpson, K. J. Millington, “The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence”, Journal of Human Nutrition and Dietetics, no. 5, 2004: 449–459.
84. A. Leaf, “Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids”, Journal of Cardiovascular Medicine, 2007: 27–29.
85. I. A. Brouwer, M. B. Katan, P. L. Zock, “Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis”, The Journal of nutrition, 2004: 919–922.
86. D. O. Koralek, U. Peters, G. Andriole, D. Reding, V. Kirsh, A. Subar, A. Schatzkin, R. Hayes, M. F. Leitzmann, “A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States)”, Cancer Causes & Control, 2006: 783–791.
87. E. Ricciotti, G. A. FitzGerald, “Prostaglandins and Inflammation”, Arteriosclerosis, Thrombosis, and Vascular Biology logo, no. 5, 2011: 986–1000.
88. S. Sierra, F. Lara-Villoslada, M. Comalada, M. Olivares, J. Xaus, “Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects”, Nutrition, no. 3, 2008: 245–254.
89. H. Mozaffari-Khosravi, M. Yassini-Ardakani, M. Karamati, Seyedeh-Elaheh Shariati-Bafghi, “Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial”, European Neuropsychopharmacology, no. 7, 2013: 636–644.
90. J. G. Martins, “EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials”, Journal of the American College of Nutrition, no. 5, 2009: 525–542.
91. M. Lucas, G. Asselin, C. Mérette, Marie-Josée Poulin, S. Dodin, “Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial”, The Journal of The North American Menopause Society, no. 2, 2009: 357–366.
92. M. Singh, “Essential fatty acids, DHA and human brain”, The Indian Journal of Pediatrics, 2005: 239–242.
93. E. K. K. Tai, X. Bo Wang, Zhen-Yu Chen, “An update on adding docosahexaenoic acid (DHA) and arachidonic acid (AA) to baby formula”, Food & function, 2013: 1767–1775.
94. C. Agostoni, S. Trojan, R. Bellù, E. Riva, M. G. Bruzzese, M. Giovannini, “Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study”, BMJ, 1997: 421–424.
95. M. H. Mohajeri, B. Troesch, P. Weber, “Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia”, Nutrition, 2015: 261–275.
96. L. A. Horrocks, Y. K. Yeo, “Health benefits of docosahexaenoic acid (DHA)”, Pharmacological Research, no. 3, 1999: 211–225.
97. T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, D. N. O’Neal, J. D. Best, L. J. Beilin, “Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men”, The American journal of nutrition, no. 5, 2000: 1085–1094. Режим доступа: http://www.ncbi.nlm.nih.gov/pubmed/10799369» \t «_blank.
98. R. S. Chapkin, D. N. McMurray, L. A. Davidson, B. S. Patil, Yang-Yi Fan, J. R. Lupton, “Bioactive dietary long chain fatty acids: Emerging mechanisms of action”, British Journal of Nutrition, no. 6, 2008: 1152–1157.
99. Q. Li, M. Wang, L. Tan, C. Wang, J. Ma, N. Li, Y. Li, G. Xu, J. Li, “Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts”, Journal of lipid research, no. 9, 2005: 1904–1913.
100. M. F. Leitzmann, M. J. Stampfer, D. S. Michaud, K. Augustsson, G. C. Colditz, W. C. Willett, E. L. Giovannucci, “Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer”, The American Journal of Clinical Nutrition, no. 1, 2004: 204–216.
101. Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA), EFSA Journal, no. 7, 2012.
102. Fish and Omega-3 Fatty Acids, American Heart Association, 2017. Режим доступа: https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/fats/fish-and-omega-3-fatty-acids#.VwWqZ_l96hc.
103. J. J. Agren, M. L. Törmälä, M. T. Nenonen, O. O. Hänninen, “Fatty acid composition of erythrocyte, platelet, and serum lipids in strict vegans”,